EFFICACY OF 5-AZACITIDINE IN THE TREATMENT OF HIGHER-RISK MYELODISPLASTIC SYNDROMES, ACUTE MYELOID LEUKEMIA AND CHRONIC MYELOMONOCYTIC LEUKEMIA: EXPERIENCE AT A SINGLE CENTER

被引：0
|
作者：
Vazquez, H. Hernandez [1 ]
Diez, E. Amutio [1 ]
Eizaguirre, I. Olazabal [1 ]
Malcorra, A. Balerdi [1 ]
Urkixo, I. Etxeguren [1 ]
Iruin, A. Uresandi [1 ]
Pomposo, M. Puente [1 ]
Usategui, M. Duenas [1 ]
Mazon, J. Mateos [1 ]
Perez, A. Iglesias [1 ]
Quintana, A. Moreto [1 ]
Frances, M. A. Pinan [1 ]
Goni, F. Floristan [1 ]
Martinez, M. C. Alvarez [1 ]
Ontoria, I. Hernandez [1 ]
Garcia-Ruiz, J. C. [1 ]
机构：
[1] Hosp Cruces, Baracaldo, Spain
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1405
引用
收藏
页码：564 / 565
页数：2
相关论文
共 50 条
  • [1] 5-Azacitidine Therapy in Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia: a Single Institution Experience
    Freyrie, Alessandra
    Reda, Gianluigi
    Vincenti, Daniele
    Sciume, Mariarita
    Binda, Francesca
    Guidotti, Francesca
    Cortelezzi, Agostino
    BLOOD, 2012, 120 (21)
  • [2] FACTORS PREDICTIVE FOR INFECTION IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES, CHRONIC MYELOMONOCYTIC LEUKEMIA AND ACUTE MYELOID LEUKEMIA TREATED WITH AZACITIDINE
    Madry, K.
    Lis, K.
    Zurawska, J.
    Gorka, M.
    Kacprzyk, P.
    Dutka, M.
    Rodzaj, M.
    Bolkun, L.
    Krochmalczyk, D.
    Drozd-Sokolowska, J.
    Waszczuk-Gajda, A.
    Knopinska-Posluszny, W.
    Kopinska, A.
    Subocz, E.
    Masternak, A.
    Guzicka-Kazimierczak, R.
    Gil, L.
    Machowicz, R.
    Dwilewicz-Trojaczek, J.
    HAEMATOLOGICA, 2017, 102 : 490 - 490
  • [3] SURVIVAL IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATMENT WITH 5-AZACITIDINE: EXPERIENCE OF A CENTER
    Busnego, M. T.
    Sanchez, A.
    Notario, C.
    Cabello, A.
    Oliva, A.
    Brena, J.
    Alberich, M. P.
    Gonzalez, H.
    Marrero, C.
    Rios, P.
    Figueroa, A.
    Hernanz, N.
    Rios, M.
    Leon, A.
    Hernandez, P.
    Hillebrand, P.
    Uribe, L.
    Mesa, M. C.
    HAEMATOLOGICA, 2019, 104 : 424 - 424
  • [4] Results of 5-azacitidine therapy in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML)
    Freyrie, A.
    Reda, G.
    Vincenti, D.
    Ferla, V.
    Orofino, N.
    Sciume, M.
    Guidotti, F.
    Cortelezzi, A.
    LEUKEMIA RESEARCH, 2013, 37 : S157 - S158
  • [5] SINGLE INSTITUTION EXPERIENCE OF 5-AZACITIDINE THERAPY IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA
    Freyrie, A.
    Guidotti, F.
    Reda, G.
    Binda, F.
    Cortelezzi, A.
    HAEMATOLOGICA, 2012, 97 : 587 - 587
  • [6] TREATMENT OF CHRONIC MYELOMONOCYTIC LEUKEMIA WITH 5-AZACITIDINE: A CASE SERIES
    Moita, F.
    Thorpe, M.
    Almeida, A.
    HAEMATOLOGICA, 2012, 97 : 588 - 588
  • [7] Determination of a Phase II Dose of Panobinostat in Combination with 5-Azacitidine in Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
    Ottmann, Oliver G.
    DeAngelo, Daniel J.
    Garcia-Manero, Guillermo
    Luebbert, Michael
    Jillella, Anand
    Sekeres, Mikkael A.
    Zahlten, Anita
    Squier, Margaret
    Acharyya, Suddhasatta
    Winiger, Ivo J.
    Fenaux, Pierre
    BLOOD, 2011, 118 (21) : 212 - 213
  • [8] RESPONSE TO 5-AZACITIDINE IN PATIENTS WITH MYELODYSPLASIC SYNDROME, CHRONIC MYELOMONOCYTIC LEUKEMIA, AND ACUTE MYELOID LEUKEMIA WITH HIGH-RISK GENETICS
    Perez Ortega, L.
    Falantes Gonzalez, J. F.
    Moya Arnau, M.
    Perez Simon, J. A.
    HAEMATOLOGICA, 2019, 104 : 293 - 294
  • [9] Glasdegib in Combination with Azacitidine in Patients with Untreated Higher-Risk Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia: Effects on Marrow Recovery and Transfusion Independence
    Zeidan, Amer
    Schuster, Michael
    Joris, Magalie
    Krauter, Juergen
    Maertens, Johan
    Gyan, Emmanuel
    Kovacsovics, Tibor
    Verma, Amit
    Vyas, Paresh
    Wang, Eunice
    Ma, Weidong
    Zeremski, Mirjana
    Kudla, Arthur
    Chan, Geoffrey
    Sekeres, Mikkael
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S191 - S192
  • [10] A Phase 1b Study of Glasdegib in Combination with Azacitidine in Patients with Untreated Higher-Risk Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia
    Sekeres, Mikkael A.
    Schuster, Michael W.
    Joris, Magalie
    Krauter, Jurgen
    Maertens, Johan A.
    Gyan, Emmanuel
    Kovacsovics, Tibor
    Verma, Amit
    Vyas, Paresh
    Wang, Eunice S.
    Ma, Weidong Wendy
    Zeremski, Mirjana
    Kudla, Arthur
    Chan, Geoffrey
    Zeidan, Amer M.
    BLOOD, 2019, 134
12345